Indexed with PubMed and Science Citation Index (E) 
Users online: 1960 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded754    
    Comments [Add]    
    Cited by others 16    

Recommend this journal


Year : 2005  |  Volume : 71  |  Issue : 4  |  Page : 262--266

An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis

1 Department of Dermatology and Venereology, S.C.B.Medical College, Cuttack, Orissa, India
2 Department of Microbiology, S.C.B.Medical College, Cuttack, Orissa, India
3 Department of Community Medicine, S.C.B.Medical College, Cuttack, Orissa, India

Correspondence Address:
Minati Mishra
698, Nayapalli, (Behind Kasturba Women's College), Bhubaneswar-12, Orissa
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.16619

Rights and Permissions

BACKGROUND: Onychomycosis is a recalcitrant disease of the nails caused by dermatophytes, yeasts, and molds. AIMS: To compare the clinical efficacy of oral itraconazole pulse therapy and oral terbinafine pulse therapy in onychomycosis. METHODS: A randomized single-blind clinical comparative study was undertaken on 120 patients of onychomycosis during the period March 1999-February 2002. Sixty patients were randomly assigned to receive oral itraconazole 100 mg, two capsules twice daily for seven days a month and the other group of sixty patients received oral terbinafine 250 mg, one tablet twice daily for seven days every month. Four such monthly pulses were administered for each drug. The patients were evaluated at 4-weekly intervals till sixteen weeks and then at 24, 36 and 48 weeks. RESULTS: We observed a clinical cure rate of 82% and mycological cure rate of 90% in the group of patients treated with itraconazole while the group with terbinafine showed clinical and mycological cure rates of 79% and 87% respectively. This difference was not statistically significant. CONCLUSIONS: Both oral itraconazole and terbinafine are effective in the treatment of onychomycosis when administered in the pulse dosage form. Terbinafine is more cost effective while itraconazole has a broader spectrum of antimycotic activity.


Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow